DalsnaFinance › IPOs › Janux Therapeutics Inc › IPO
Janux Therapeutics, Inc. completed its initial public offering on NASDAQ on June 11, 2021, pricing at $17.00 a share.
| Ticker | JANX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 11, 2021 |
| Offering price | $17.00 |
| Shares offered | 11,400,000 |
| Total raised | $194M |
Janux Therapeutics, Inc. sold 11,400,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $193.8 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $194 million total recorded for the deal.
Janux Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Janux Therapeutics, Inc.. This page is general information, not investment advice.